0000899243-16-033097.txt : 20161109
0000899243-16-033097.hdr.sgml : 20161109
20161109202928
ACCESSION NUMBER: 0000899243-16-033097
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161107
FILED AS OF DATE: 20161109
DATE AS OF CHANGE: 20161109
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CORCEPT THERAPEUTICS INC
CENTRAL INDEX KEY: 0001088856
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770487658
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 149 COMMONWEALTH DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650.688.8803
MAIL ADDRESS:
STREET 1: 149 COMMONWEALTH DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BELANOFF JOSEPH K
CENTRAL INDEX KEY: 0001286199
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50679
FILM NUMBER: 161985650
MAIL ADDRESS:
STREET 1: 149 COMMONWEALTH DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-11-07
0
0001088856
CORCEPT THERAPEUTICS INC
CORT
0001286199
BELANOFF JOSEPH K
C/O CORCEPT THERAPEUTICS INCORPORATED
149 COMMONWEALTH DRIVE
MENLO PARK
CA
94025
1
1
0
0
CHIEF EXECUTIVE OFFICER
Common Stock
2016-11-07
4
M
0
93533
1.50
A
2257728
D
Common Stock
2016-11-07
4
S
0
93533
8.2212
D
2164195
D
Common Stock
2016-11-07
4
M
0
406467
1.50
A
2570662
D
Common Stock
2016-11-07
4
S
0
406467
8.3244
D
2164195
D
Stock Option (Right to Buy)
1.50
2016-11-07
4
M
0
93533
0.00
D
2017-04-16
Common Stock
93533
906467
D
Stock Option (Right to Buy)
1.50
2016-11-07
4
M
0
406467
0.00
D
2017-04-16
Common Stock
406467
500000
D
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $8.22 to $8.24 per share. Detailed information on the exact number of shares sold at each sale price can be obtained upon request.
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $8.27 to $8.375 per share. Detailed information on the exact number of shares sold at each sale price can be obtained upon request.
Fully exercisable.
/s/ Charles Robb, Attorney-in-Fact for Joseph K. Belanoff
2016-11-09